"Psychedelic Medicine: The Future of Mental Health" Panel at Space Park Miami
Updated: Apr 18
For almost a year, Dustin Robinson, Esq. CPA has been hosting a monthly Psychedelic Series at Soho Beach House Miami. As a result of the series’ success, Robinson is partnering with Space Park Miami to host “Psychedelic Medicine: The Future of Mental Health” on Saturday, April 16.
Presented by Nucleus and LinkMiamiRebels, Michelle Weiner, DO, MPH, psychedelic expert at Spine and Wellness Centers of America, and Julia Mirer, MD, consultant in the emerging field of psychedelic medicine, will join Robinson for this free panel to discuss the progress in medicine with the help of psychedelics.
At the event, attendees will learn firsthand how psychedelics are paving the way for many medicinal advancements. The panel will follow the 4:20 p.m. Space Park Yoga class.
Dr. Michelle Weiner is double board-certified in Interventional Pain Medicine and Physical Medicine and Rehabilitation. Dr. Weiner focuses on diagnosing and treating spine and musculoskeletal pain as well as chronic migraines at the Spine and Wellness Centers of America. Her unique approach of personalized and preventative medicine focuses on empowering her patients to cultivate health using lifestyle and plant medicine. Her research focuses on using cannabis as a substitute for opioids in chronic pain patients and cannabis’ effect on seniors with chronic pain. Dr. Weiner is the Vice President of Mr. Psychedelic Law and on the Advisory Board for Iter Investments. She uses cannabis and ketamine-assisted psychotherapy as a catalyst to identify the root cause of one’s suffering, optimizing their quality of life.
Dr. Julia Mirer is a consultant in the emerging field of psychedelic medicine, serving as a bridge between eastern and western practices, committed to merging them to help create a new paradigm for integrative health and wellness. She was on the road to a career in pediatrics, but decided to shift gears to explore transformative medicine where she has found her calling in education and advocacy for the responsible use of these medicines. Dr. Mirer believes that a successful future for this field depends on the interplay between policy, research, and clinics and has therefore positioned herself to play a role in each. Nationally, she is an advisor for the Psychedelic Medicine Coalition, lobbying for NIH funding for psychedelic research. In Florida, she is a facilitator for FDA clinical trials with psychedelics. Most recently, Dr. Mirer joined Nushama as director of strategy, where she hopes to combine all her experience to create the vision of a new kind of healthcare system and facilitate Nushama’s goal of humanizing medicine.
Robinson is Founding Partner of Mr. Cannabis Law; Co-Founder of Mr. Psychedelic Law; and Managing Principal of Iter Investments. Along with Iter Investments, he recently launched Nucleus, a data-driven psychedelics platform that is focused on mental health data and technologies.
The event free and open to the public, ages 18 and up.